secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001641172-25-013620
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix appoints Doron Besser as CEO; Brian Murphy retires but stays on board
--------------------------------------------------------------------------------

- Brian Murphy retired as CEO of NanoVibronix effective June 4, 2025, and will remain as a director.
- Doron Besser, previously CEO of subsidiary ENvue Medical Holdings, appointed as CEO effective same date.
- NanoVibronix completed acquisition of ENvue on February 14, 2025, creating a combined growth platform.
- Besser has a medical device background; previously helped lead superDimension, acquired by Covidien for ~$300M.
- Board Chairman Christopher Fashek thanked Murphy and expressed confidence in Besser's leadership.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000164117225013620/0001641172-25-013620-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000164117225013620/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013620

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer